A detailed history of Bridgeway Capital Management, LLC transactions in Omeros Corp stock. As of the latest transaction made, Bridgeway Capital Management, LLC holds 161,300 shares of OMER stock, worth $1.66 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
161,300
Previous 161,300 -0.0%
Holding current value
$1.66 Million
Previous $654,000 2.14%
% of portfolio
0.01%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$2.88 - $4.89 $72,000 - $122,249
-25,000 Reduced 13.42%
161,300 $556,000
Q4 2023

Feb 14, 2024

BUY
$1.08 - $3.63 $83,268 - $279,873
77,100 Added 70.6%
186,300 $609,000
Q2 2023

Aug 14, 2023

SELL
$4.45 - $7.57 $133,500 - $227,100
-30,000 Reduced 21.55%
109,200 $594,000
Q4 2022

Feb 14, 2023

BUY
$1.75 - $3.96 $68,600 - $155,232
39,200 Added 39.2%
139,200 $314,000
Q3 2022

Nov 14, 2022

BUY
$3.09 - $7.46 $309,000 - $746,000
100,000 New
100,000 $315,000

Others Institutions Holding OMER

About OMEROS CORP


  • Ticker OMER
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,730,000
  • Market Cap $647M
  • Description
  • Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...
More about OMER
Track This Portfolio

Track Bridgeway Capital Management, LLC Portfolio

Follow Bridgeway Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgeway Capital Management, LLC with notifications on news.